Physician profile
Christopher Perez
NPI 1215974944
$16,322.65
in general payments reported to CMS, 2019-2025
10 companies · $521 in 2025
The $521 reported for 2025 was more than what 93% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,013 · 2020: $4,800 · 2021: $4,830 · 2022: $129 · 2023: $356 · 2024: $673 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,550.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $14,400.00 | 2019-2021 | |
| Medtronic, INC. | $683.06 | 2021-2025 | Venaseal, Closurefast |
| Boston Scientific Corporation | $619.34 | 2023-2025 | Varithena Administration Pack, General - Pain Management |
| Medtronic Vascular, INC. | $198.06 | 2019 | |
| Tactile Systems Technology INC | $190.62 | 2019-2025 | Flexitouch Plus, Nimbl |
| Abbott Laboratories | $154.34 | 2023 | Cardiomems |
| Cashflow Solutions, LLC | $23.85 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Progenacare Global, LLC | $20.29 | 2023 | |
| Depuy Synthes Sales INC. | $18.31 | 2025 | Monovisc, Orthovisc |
| Bard Access Systems, INC. | $14.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.